Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Current Leases (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Current Leases for 2 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 16.69% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, up 16.69% year-over-year, with the annual reading at $1.7 million for FY2025, 16.69% up from the prior year.
  • Current Leases for Q4 2025 was $1.7 million at Pyxis Oncology, up from $1.6 million in the prior quarter.
  • The five-year high for Current Leases was $1.7 million in Q4 2025, with the low at $1.0 million in Q1 2024.